Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026)
Bausch & Lomb (BLCO) reported Non-Current Deferred Tax Liability of $19.0 million for Q1 2026, up 46.15% on a YoY basis from $13.0 million in Q1 2025, and little changed quarter-over-quarter from $19.0 million in Q4 2025.
Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Non-Current Deferred Tax Liability for 6 years, with the latest figure at $19.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 46.15% year-over-year to $19.0 million; the trailing twelve-month figure through Mar 2026 stood at $19.0 million (up 46.15% YoY), and the FY2025 full-year result was $19.0 million, up 46.15% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $19.0 million, roughly flat from $19.0 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $103.0 million in Q1 2022, with the low at $7.0 million in Q4 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $18.5 million across 5 years, with a median of $14.0 million in 2023.
- The largest YoY upside for Non-Current Deferred Tax Liability was 100.0% in 2023 against a maximum downside of 86.41% in 2023.
- Bausch & Lomb's Non-Current Deferred Tax Liability stood at $7.0 million in 2022, then surged by 100.0% to $14.0 million in 2023, then retreated by 7.14% to $13.0 million in 2024, then jumped by 46.15% to $19.0 million in 2025, then changed by 0.0% to $19.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $19.0 million (Q1 2026), $19.0 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 14.00 Mn |
| Dec 31, 2023 | 14.00 Mn |